Is there any association between uterine malignant mixed Mullerian tumour, breast cancer and prolonged tamoxifen treatment?

J Obstet Gynaecol. 2003 May;23(3):301-3. doi: 10.1080/01443610310000100150.

Abstract

Uterine malignant mixed Mullerian tumour is a very aggressive tumour of unknown aetiology. Previous pelvic irradiation, excessive oestrogen exposure, obesity and nulliparity have been incriminated in its aetiology. There is a paucity of data on the association between uterine mixed Mullerian tumour breast cancer and prolonged tamoxifen treatment. We report four patients who took tamoxifen for more than 7 years for breast cancer prior to their diagnosis with uterine mixed Mullerian tumour and also reviewed similar cases reported in the medical literature. The purpose of this article is to draw the attention of other professionals on this subject.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Breast Neoplasms / prevention & control*
  • Carcinoma, Ductal, Breast / prevention & control*
  • Estrogen Antagonists / adverse effects
  • Estrogen Antagonists / therapeutic use*
  • Female
  • Humans
  • Mixed Tumor, Mullerian / chemically induced*
  • Mixed Tumor, Mullerian / surgery
  • Tamoxifen / adverse effects
  • Tamoxifen / therapeutic use*
  • Uterine Neoplasms / chemically induced*
  • Uterine Neoplasms / surgery

Substances

  • Estrogen Antagonists
  • Tamoxifen